Latin America Oxygen Therapy Market Report

Latin America Oxygen Therapy Market Size

The Latin America Oxygen Therapy Market size was valued at USD 0.32 billion in 2024. The Oxygen Therapy Market size in Latin America was worth USD 0.34 billion in 2024 and is estimated to be growing at a CAGR of 6.93% to reach USD 0.58 billion by 2033. Oxygen therapy involves administering oxygen through an external device.

Oxygen therapy refers to the administration of medical oxygen for treating patients suffering from conditions that impair normal oxygen intake, such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and cardiovascular disorders. In the Latin American region, the demand for oxygen therapy has grown significantly due to an aging population, rising prevalence of respiratory diseases, and increased awareness about home-based care solutions. According to the Pan American Health Organization (PAHO), respiratory illnesses account for a substantial proportion of hospitalizations across Latin America, particularly in countries with high air pollution levels like Mexico and Colombia. Moreover, the aftermath of the global pandemic further emphasized the importance of oxygen supply infrastructure in both hospital and outpatient settings. Brazil and Argentina have made notable strides in expanding public healthcare initiatives related to oxygen therapy, while private sector players are increasingly offering portable and cost-effective oxygen devices.

MARKET DRIVERS

Rising Prevalence of Chronic Respiratory Diseases

A primary driver of the Latin America oxygen therapy market is the increasing incidence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), COPD affects approximately 12% of the adult population in several Latin American countries, with high rates of underdiagnosis and delayed treatment. The rise in tobacco use, exposure to industrial pollutants, and urban air quality issues further exacerbate respiratory ailments. As per the World Health Organization (WHO), smoking prevalence among men in Argentina exceeds 25%, significantly contributing to lung function deterioration. Additionally, environmental factors such as biomass fuel usage in rural areas of Peru and Bolivia have been linked to higher rates of chronic bronchitis and emphysema. The resulting demand for long-term oxygen therapy (LTOT) has spurred growth in both institutional and home care settings.

Expansion of Home Healthcare Services

Another key driver of the Latin America oxygen therapy market is the rapid expansion of home healthcare services, supported by technological advancements and shifting patient preferences toward outpatient care. The convenience, cost-effectiveness, and improved quality of life associated with home-based oxygen therapy have led to a surge in demand for portable oxygen concentrators and refillable oxygen cylinders. Additionally, as per Frost & Sullivan, the Latin American telehealth market grew by more than 60% during the pandemic, facilitating remote monitoring of patients receiving oxygen therapy. This trend has encouraged manufacturers to develop lightweight, battery-operated oxygen devices tailored for home use. In Argentina, national health authorities have introduced reimbursement policies for home oxygen therapy, enhancing accessibility for low-income populations.

MARKET RESTRAINTS

Limited Access to Medical Oxygen Infrastructure in Rural Areas

One of the most significant restraints affecting the Latin America oxygen therapy market is the inadequate availability of medical oxygen infrastructure in rural and underserved regions. Many remote communities lack reliable electricity, centralized oxygen supply systems, and trained healthcare personnel to administer oxygen therapy effectively. As per a study published by the Pan American Journal of Public Health, only 35% of rural hospitals in Honduras have functioning oxygen delivery systems, severely limiting treatment options for patients with acute respiratory distress. In addition to supply constraints, logistical challenges in transporting and maintaining oxygen cylinders and concentrators hinder widespread adoption. As per the United Nations Children's Fund (UNICEF), distribution inefficiencies and poor road networks make it difficult to deliver oxygen supplies to remote clinics on time. These infrastructural limitations continue to impede market growth and equitable access to oxygen therapy across Latin America.

High Cost of Advanced Oxygen Delivery Devices

The high cost of advanced oxygen delivery devices remains a critical barrier to the widespread adoption of oxygen therapy in Latin America. While modern technologies such as portable oxygen concentrators and pulse-dose systems offer enhanced mobility and efficiency, their relatively high acquisition and maintenance costs limit affordability for many patients. Additionally, according to the Mexican Institute of Social Security (IMSS), reimbursement coverage for oxygen therapy remains inconsistent across the country, with many low-income families unable to afford out-of-pocket expenses.

MARKET OPPORTUNITIES

Integration of Telehealth and Remote Monitoring Systems

A promising opportunity for the Latin America oxygen therapy market lies in the integration of telehealth and remote monitoring systems into respiratory care. The rapid digital transformation in healthcare, accelerated by the global pandemic, has opened new avenues for managing chronic respiratory conditions outside hospital settings. Telemonitoring allows healthcare providers to track patients' oxygen saturation levels, adjust therapy regimens, and provide timely interventions without requiring physical visits. In Argentina, the Ministry of Health has initiated pilot programs integrating telehealth platforms with home oxygen therapy services to improve patient compliance and outcomes.

Government Initiatives and Policy Reforms Supporting Respiratory Care

Government-led initiatives and policy reforms aimed at strengthening respiratory care infrastructure represent a significant opportunity for the Latin America oxygen therapy market. Several national health agencies are prioritizing chronic disease management and emergency oxygen supply preparedness, particularly in response to lessons learned from the pandemic. According to the Pan American Health Organization (PAHO), Brazil’s Ministry of Health launched the "National Plan for Pulmonary Hypertension and Chronic Respiratory Diseases" in 2023, which includes provisions for expanding oxygen therapy access in public hospitals. Similarly, in Colombia, the Ministry of Social Protection has introduced subsidies for low-income patients requiring long-term oxygen therapy (LTOT). Additionally, as per the Mexican Institute of Social Security (IMSS), insurance coverage for oxygen therapy has expanded under recent healthcare reforms, benefiting millions of beneficiaries. These regulatory shifts not only enhance affordability but also encourage private sector participation in developing cost-effective oxygen therapy solutions tailored to regional needs.

MARKET CHALLENGES

Regulatory Complexity and Standardization Gaps

A major challenge facing the Latin America oxygen therapy market is the fragmented regulatory landscape and lack of standardized approval processes across the region. According to the Pan American Health Organization (PAHO), only eight out of 20 Latin American countries have fully functional regulatory frameworks for medical devices. In Peru and Ecuador, for example, local certification procedures add significant time and cost burdens for international manufacturers seeking market entry. Furthermore, as per the Brazilian Health Regulatory Agency (ANVISA), inconsistencies in classification criteria lead to confusion regarding whether certain oxygen delivery devices qualify as medical equipment or consumer goods. These regulatory hurdles create operational inefficiencies and discourage investment in innovative oxygen therapy products by posing a persistent challenge to market expansion.

Shortage of Trained Healthcare Professionals

Another pressing challenge in the Latin America oxygen therapy market is the shortage of trained healthcare professionals capable of administering and managing oxygen therapy effectively. Despite growing demand, there remains a significant gap in specialized respiratory therapists, pulmonologists, and technicians required to operate and maintain oxygen delivery systems.

According to the World Health Organization (WHO), Latin America faces one of the lowest physician-to-population ratios globally, with some countries reporting fewer than two doctors per 1,000 people. In addition, as per a study published by the Pan American Journal of Public Health, only 20% of rural health workers in Guatemala received formal instruction on oxygen administration techniques. This knowledge gap limits the effective deployment of oxygen therapy, particularly in emergency and home care settings.

SEGMENTAL ANALYSIS

By Product Type Insights

The oxygen delivery devices segment was the largest and held 57.2% of the Latin America oxygen therapy market share in 2024. According to the Pan American Health Organization (PAHO), over 60% of patients receiving long-term oxygen therapy (LTOT) in Latin America rely on nasal cannulas due to their comfort, ease of use, and cost-effectiveness. Additionally, as per Frost & Sullivan, the demand for high-flow nasal cannula systems has surged in hospitals treating respiratory distress cases, particularly in Brazil and Mexico. Moreover, the increasing adoption of portable oxygen concentrators has further strengthened this segment’s position. As per a report by McKinsey & Company, sales of portable oxygen delivery systems in Argentina rose by over 25% between 2021 and 2023.

The oxygen source equipment segment is projected to register a CAGR of 9.4% during the forecast period. This rapid expansion is attributed to the increasing deployment of medical oxygen concentrators, liquid oxygen systems, and compressed oxygen cylinders in homecare environments. According to the World Health Organization (WHO), more than 8 million people in Latin America suffer from moderate to severe COPD, creating a strong demand base for oxygen concentrators. In Brazil alone, the Ministry of Health reported a 30% increase in prescriptions for home oxygen therapy between 2021 and 2023. Additionally, government initiatives aimed at strengthening emergency oxygen supply infrastructure have accelerated market growth. As per the Inter-American Development Bank (IDB), Brazil and Colombia have allocated significant funds to equip rural health centers with stationary oxygen generators.

By Application Insights

The Chronic obstructive pulmonary disease (COPD) segment was the largest by occupying 41.2% of the Latin America oxygen therapy market share in 2024. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), nearly 12% of adults aged above 40 in several Latin American countries suffer from COPD, with smoking, air pollution, and occupational exposure being primary risk factors. In Mexico, the National Institute of Respiratory Diseases (INER) reports that COPD is among the top five causes of mortality, leading to increased oxygen therapy utilization. Furthermore, as per the Pan American Health Organization (PAHO), COPD-related hospitalizations have risen by over 20% in the past five years, reinforcing the need for effective therapeutic interventions. Long-term oxygen therapy is a standard recommendation for patients with severe hypoxemia, improving survival rates and quality of life.

The pneumonia segment is swiftly emerging with a CAGR of 10.2% during the forecast period with the increasing incidence of bacterial and viral pneumonia among vulnerable populations such as children and the elderly. According to the World Health Organization (WHO), lower respiratory infections, including pneumonia, remain a leading cause of death among children under five in Latin America, especially in low-income regions of Peru, Bolivia, and Honduras. In response, national health agencies have intensified efforts to improve oxygen availability in pediatric wards.  Additionally, the aftermath of the global pandemic has heightened awareness regarding acute respiratory distress syndrome (ARDS) associated with viral pneumonia, prompting governments to invest in emergency oxygen infrastructure.

By End-user Insights

The hospitals segment dominated the Latin America oxygen therapy market share in 2024. According to the Pan American Health Organization (PAHO), nearly 70% of all oxygen therapy administrations in Latin America occur within hospital settings, particularly in intensive care and emergency departments. In Brazil, as per the Ministry of Health, over 80% of public hospitals have dedicated oxygen pipelines supplying centralized oxygen systems to patient wards. Similarly, in Mexico, the National Institute of Respiratory Diseases (INER) mandates that all Level III hospitals maintain sufficient oxygen storage and delivery capacity. Furthermore, as per Frost & Sullivan, hospital procurement of oxygen concentrators and bulk oxygen tanks has increased by over 25% since 2021, largely driven by investments in pandemic preparedness and emergency care infrastructure.

The home healthcare segment isCAGR of around 9.8%. This acceleration is fueled by shifting patient preferences toward outpatient care, technological advancements in portable oxygen devices, and supportive policy reforms. Government reimbursement policies have also played a pivotal role in boosting home oxygen therapy uptake. In Mexico, the Social Security Institute (IMSS) introduced coverage for home oxygen therapy in 2022, benefiting thousands of COPD patients.

REGIONAL ANALYSIS

Brazil Oxygen Therapy Market Insights

Brazil was accounted in holding 34.1% of the Latin America oxygen therapy market share in 2024. According to the Brazilian Ministry of Health, COPD affects over 8 million adults nationwide, making it a leading cause of hospitalization and mortality. In response, the government has implemented programs such as the "National Plan for Pulmonary Hypertension and Chronic Respiratory Diseases" to enhance oxygen therapy accessibility. As per the Pan American Health Organization (PAHO), Brazil has significantly expanded its ICU bed capacity and centralized oxygen supply systems in recent years, particularly following the pandemic.

Additionally, as per Frost & Sullivan, Brazil's private healthcare sector has witnessed a surge in home oxygen therapy services, with telehealth integration playing a crucial role. Companies like Air Liquide and Linde Healthcare have strengthened their presence in the country, contributing to market expansion.

Mexico Oxygen Therapy Market Insights

Mexico ranked second with 25.3% of the Latin America oxygen therapy market share in 2024. As per the Mexican Institute of Social Security (IMSS), over 5 million individuals suffer from chronic respiratory ailments, necessitating widespread oxygen therapy adoption. The country has also seen an increase in ICU admissions requiring oxygen support during seasonal flu outbreaks and the pandemic. Private companies such as Grupo Gamma and Dasa have integrated oxygen therapy into chronic disease management programs. Additionally, government-led initiatives like the National Strategy for Non-Communicable Diseases aim to strengthen early diagnosis and treatment, further propelling market growth.

Argentina Therapy Market Insights

Argentina is likely to showcase huge growth opportunities in the next coming years. According to the Argentine Society of Pulmonology (SAP), COPD affects over 1.2 million people in Argentina, with many requiring long-term oxygen therapy (LTOT). As per the Ministry of Health, the country has expanded its home healthcare services through policies that subsidize oxygen equipment for low-income patients. Public-private partnerships have also contributed to market growth. In 2023, the government collaborated with international medical device manufacturers to distribute oxygen concentrators to underserved provinces.

Chile Oxygen Therapy Market Insights

Chile oxygen therapy market is growing with its advanced healthcare infrastructure and proactive public health policies. The country maintains one of the highest healthcare expenditure levels in the region, supporting the adoption of modern oxygen therapy technologies. According to the Chilean Ministry of Health, the country has one of the lowest infant mortality rates and a well-established primary care network, facilitating early diagnosis and intervention for respiratory conditions. In recent years, Chile has become a hub for clinical research related to respiratory care. As per the University of Chile, several studies have explored the efficacy of oxygen therapy in COPD and sleep apnea patients.

Colombia Oxygen Therapy Market Insights

Colombia oxygen therapy market growth is driven by expanding healthcare access and rising government emphasis on chronic disease management. The country has made notable strides in improving public health infrastructure, particularly in urban and semi-urban areas. Private sector participation has also grown, with companies like Clínica del Country and Air Liquide expanding their oxygen therapy offerings. Government-backed insurance schemes and increasing awareness about home-based care are expected to drive continued growth in Colombia’s oxygen therapy market.

KEY MARKET PLAYERS AND COMPETITIVE LANDSCAPE

Prominent companies leading the LATAM Oxygen Therapy Market are Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc., and Respan Products Inc.

The Latin America dicamba herbicide market is characterized by intense competition driven by the dominance of multinational agrochemical firms and the growing influence of domestic players. Market participants compete not only on product formulation and pricing but also through technological differentiation and regulatory compliance. The demand for effective post-emergence herbicides, particularly in soybean and cotton cultivation, has intensified rivalry as companies strive to secure contracts with large-scale agribusinesses and cooperatives.

A significant battleground is the development of low-volatility dicamba formulations that reduce off-target movement and meet stringent environmental standards. Companies are increasingly integrating these products with herbicide-tolerant crop systems to offer comprehensive weed management solutions. Strategic alliances with biotech seed producers have become essential for ensuring compatibility and maximizing adoption. Additionally, localized distribution networks and agronomic support services are being leveraged to strengthen customer relationships and improve product accessibility in rural areas.

While established players such as BASF, Corteva, and Syngenta maintain a strong foothold, smaller domestic and regional firms are gaining traction by offering cost-effective alternatives. This dynamic environment fosters continuous innovation, compelling firms to invest in research, expand their service offerings, and adapt swiftly to shifting regulatory and market conditions.

Top Players in the Latin America Oxygen Therapy Market

Air Liquide Healthcare

Air Liquide Healthcare is a subsidiary of the French multinational industrial gas giant, plays a leading role in the Latin America oxygen therapy market. The company provides medical gases and associated equipment to both institutional and home healthcare settings. In Latin America, it has established a strong presence through local partnerships, distribution networks, and patient support programs. Its focus on innovation and reliability ensures consistent supply and service excellence, making it a preferred provider among hospitals and clinics across the region.

Linde Healthcare

Linde Healthcare, part of the global Linde plc group, is a major player in medical gas solutions, including oxygen therapy products and services. In Latin America, the company has expanded its reach by investing in regional manufacturing, logistics, and customer-centric care models. It collaborates with public health systems and private providers to enhance access to oxygen therapy for chronic respiratory conditions.

Grupo Gamma

Grupo Gamma is one of the most prominent regional players in Mexico’s healthcare sector and a key contributor to the Latin America oxygen therapy market. The company offers a wide range of respiratory care products, including portable oxygen concentrators, cylinders, and delivery devices. Its strategic expansion into telehealth and homecare services has made oxygen therapy more accessible to patients across urban and semi-urban areas. Grupo Gamma’s localized approach, combined with its integration of digital health tools that strengthens its position as a trusted provider in the region.

Top Strategies Used by Key Market Participants in the Latin America Dicamba Herbicide Market

One major strategy employed by key players in the Latin America dicamba herbicide market is product formulation development to address drift and volatility concerns by ensuring compliance with regulatory standards while maintaining weed control efficacy. Companies are investing heavily in low-volatility formulations that minimize off-target movement and environmental impact.

Another critical approach is strategic alliances with biotech seed companies to promote integrated weed management systems, particularly those involving dicamba-tolerant genetically modified crops. These collaborations help ensure compatibility between herbicides and crop varieties, enhancing adoption among large-scale farmers.

Localized agronomic support and farmer education initiatives are being leveraged to strengthen market positions. Companies are conducting field trials, training sessions, and direct engagement programs to build trust, improve product understanding, and drive sustainable usage practices tailored to regional agricultural needs.

RECENT MARKET DEVELOPMENTS

• In January 2023, Air Liquide Healthcare launched a new mobile oxygen delivery program in Brazil, aimed at improving access to oxygen therapy in underserved rural communities. This initiative was designed to support remote patient care and enhance emergency response capabilities.
• In August 2023, Linde Healthcare partnered with a Chilean telemedicine platform to integrate real-time oxygen saturation monitoring for COPD patients receiving home-based oxygen therapy, strengthening remote patient management and treatment adherence.
• In March 2024, Grupo Gamma introduced a line of lightweight, battery-operated oxygen concentrators tailored for Mexican consumers, focusing on mobility and ease of use to cater to the rising demand for home healthcare solutions.
• In November 2024, BD (Becton, Dickinson and Company) expanded its distribution network in Colombia by collaborating with local pharmacies to provide oxygen delivery devices directly to patients by reducing supply chain delays and increasing product availability.
• In May 2025, Philips Respironics, a leader in respiratory care, launched an educational campaign in Argentina targeting physicians and caregivers on best practices for oxygen therapy administration, aiming to improve clinical outcomes and increase device adoption across home and hospital settings.

MARKET SEGMENTATION

This research report on the Latin America Oxygen Therapy Market has been segmented & sub-segmented into the following categories.

By Product Type

• Oxygen Source Equipment
  • Oxygen Concentrators   
    • Fixed Oxygen Concentrators
    • Portable Oxygen Concentrators
  • Liquid Oxygen Devices   
  • Oxygen Cylinders             
• Oxygen Delivery Devices                  
  • Oxygen Masks   
  • Nasal Cannulas  
  • Venturi Masks   
  • Non-Rebreather Masks 
  • Bag Valve Masks               
  • Other Devices    

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Obstructive Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Pneumonia

By End-user

• Home Healthcare
• Hospitals

By Country

• Brazil
• Argentina
• Chile
• Rest of Latin America